Stock GLTO GALECTO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Galecto, Inc.

Equities

GLTO

US36322Q1076

Delayed Nasdaq
Other stock markets
 10:46:12 2024-06-04 am EDT 		5-day change 1st Jan Change
0.61 USD -1.45% Intraday chart for Galecto, Inc. -2.12% -15.28%
May. 01 Galecto, Inc. Announces First Patient Dosed in an Investigator-Initiated Phase 2 Trial of GB1211 in Combination with Pembrolizumab CI
Apr. 29 Galecto, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
GALECTO, INC.
Bio Therapeutic Drugs
-1.45%-2.12%-15.28%-73.01% - 16.78M
Bearish
Neutral
Bearish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. GLTO Stock
  4. Charts Galecto, Inc.
  5. Comparison Chart